Your browser doesn't support javascript.
loading
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
Ma, Yuanqing; Joyce, Allison; Brandenburg, Olivia; Saatchi, Faeze; Stevens, Christina; Toffessi Tcheuyap, Vanina; Christie, Alana; Do, Quyen N; Fatunde, Oluwatomilade; Macchiaroli, Alyssa; Wong, So C; Woolford, Layton; Yousuf, Qurratulain; Miyata, Jeffrey; Carrillo, Deyssy; Onabolu, Oreoluwa; McKenzie, Tiffani; Mishra, Akhilesh; Hardy, Tanner; He, Wei; Li, Daniel; Ivanishev, Alexander; Zhang, Qing; Pedrosa, Ivan; Kapur, Payal; Schluep, Thomas; Kanner, Steven B; Hamilton, James; Brugarolas, James.
Affiliation
  • Ma Y; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Joyce A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Brandenburg O; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Saatchi F; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Stevens C; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Toffessi Tcheuyap V; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Do QN; O'Donnell School of Public Health, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Fatunde O; Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Macchiaroli A; Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Wong SC; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Woolford L; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Yousuf Q; Arrowhead Pharmaceuticals, Pasadena, California.
  • Miyata J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Carrillo D; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Onabolu O; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • McKenzie T; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Mishra A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Hardy T; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • He W; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Li D; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Ivanishev A; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Zhang Q; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Pedrosa I; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Kapur P; Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Schluep T; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Kanner SB; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Hamilton J; Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Brugarolas J; Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas, Texas.
Clin Cancer Res ; 28(24): 5405-5418, 2022 12 15.
Article in En | MEDLINE | ID: mdl-36190432
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia / Carcinoma, Renal Cell / Kidney Neoplasms Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia / Carcinoma, Renal Cell / Kidney Neoplasms Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Type: Article